Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02024685 · ClinicalTrials.gov registry record · NA

Treatment Decision Analysis Model for Prostate Cancer: A Randomized Trial

A NA study, sponsored by Case Comprehensive Cancer Center.

Terminated
Registry status
NA
Development phase
76
Enrollment target

NCT02024685 is a NA study that was terminated before completion, run by Case Comprehensive Cancer Center. The registered enrollment target is 76 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02024685, a NA study, was terminated before completion, sponsored by Case Comprehensive Cancer Center.

TERMINATED
Registry status
NA
Development phase
76 participants
Enrollment target

Study Summary

This is a psychosocial/behavioral study and does not involve administration of any treatment or diagnostic procedures. We will use a randomized trial to test the hypothesis that a decision analysis model that provides individualized estimates of quality-adjusted disease-free survival for each of the treatment options for clinically localized prostate cancer will lead to higher quality treatment decisions congruent with a patient's values leading to improved decisional regret and treatment satisfaction. In this trial, all patients would be evaluated at baseline for their utilities for various clinically important health states. The control arm will receive counseling regarding treatment options using standard patient-physician interactions and nomogram-predicted probabilities of treatment outcome for the various treatment options and they will be unaware of the decision analysis recommendation. The treatment arm would be counseled using standard patient-physician interactions and they would also be provided with a personalized treatment recommendations based on the decision analysis model prior to treatment selection. The primary endpoint of this study will be regret-free survival at 2 years after treatment. There will be a 1:1 randomization. A random permuted design will be used to assure approximate balanced number of patients in the two groups over time.

Interventions

  • BEHAVIORAL Personalized Treatment Recommendations
  • BEHAVIORAL Standard patient-physician counseling interaction

Trial Details

FieldValue
Enrollment Target 76 participants
Start Date 2013-08
Est. Completion 2014-05
Phase NA

Sponsor

Case Comprehensive Cancer Center

407 total trials

What the Registry Record Tells You About NCT02024685

The ClinicalTrials.gov registry entry for NCT02024685 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Personalized Treatment Recommendations is the first listed.

NCT02024685 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02024685 about?

NCT02024685 is a clinical study titled "Treatment Decision Analysis Model for Prostate Cancer: A Randomized Trial". This is a psychosocial/behavioral study and does not involve administration of any treatment or diagnostic procedures. We will use a randomized trial to test the hypothesis that a decision analysis model that provides individualized estimates of quality-adjusted disease-free survival for each of the...

What is the current status of trial NCT02024685?

This trial is currently terminated. It is a NA study. The enrollment target is 76 participants. The study started on 2013-08. Estimated completion is 2014-05.

What interventions are being tested in trial NCT02024685?

The interventions under investigation include: Personalized Treatment Recommendations (BEHAVIORAL), Standard patient-physician counseling interaction (BEHAVIORAL).

Who is sponsoring clinical trial NCT02024685?

This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.